Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Schubbert

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Molecular Cancer Therapeutics|May 13, 2024
IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell ExpansionJi Li, Robyn Clark, Dionysos Slaga, et al.
Human Mutation|November 6, 2007
Mutation analysis in Costello syndrome: functional and structural characterization of the HRAS p.Lys117Arg mutationEllen Denayer, Annabel Parret, Magdalena Chmara, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 1, 2025
A quantitative systems pharmacology model to inform clinical translation of dynamic PKPD relationships of engineered IL-15Louis R Joslyn, Mohammad Jafarnejad, Rajbharan Yadav, et al.
Blood|December 3, 2003
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesisMignon L Loh, Shashaank Vattikuti, Suzanne Schubbert, et al.
Nature Genetics|February 14, 2006
Germline KRAS mutations cause Noonan syndromeSuzanne Schubbert, Martin Zenker, Sara L Rowe, et al.
Frontiers in Pharmacology|June 18, 2024
Translational PK/PD and the first-in-human dose selection of a PD1/IL15: an engineered recombinant targeted cytokine for cancer immunotherapyRajbharan Yadav, Suzanne Schubbert, Patrick G Holder, et al.
American Journal of Medical Genetics. Part A|December 17, 2009
Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and backKatherine A Rauen, Lisa Schoyer, Frank McCormick, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Molecular Cancer Therapeutics|May 13, 2024
IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell ExpansionJi Li, Robyn Clark, Dionysos Slaga, et al.
Human Mutation|November 6, 2007
Mutation analysis in Costello syndrome: functional and structural characterization of the HRAS p.Lys117Arg mutationEllen Denayer, Annabel Parret, Magdalena Chmara, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 1, 2025
A quantitative systems pharmacology model to inform clinical translation of dynamic PKPD relationships of engineered IL-15Louis R Joslyn, Mohammad Jafarnejad, Rajbharan Yadav, et al.
Blood|December 3, 2003
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesisMignon L Loh, Shashaank Vattikuti, Suzanne Schubbert, et al.
Nature Genetics|February 14, 2006
Germline KRAS mutations cause Noonan syndromeSuzanne Schubbert, Martin Zenker, Sara L Rowe, et al.
Frontiers in Pharmacology|June 18, 2024
Translational PK/PD and the first-in-human dose selection of a PD1/IL15: an engineered recombinant targeted cytokine for cancer immunotherapyRajbharan Yadav, Suzanne Schubbert, Patrick G Holder, et al.
American Journal of Medical Genetics. Part A|December 17, 2009
Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and backKatherine A Rauen, Lisa Schoyer, Frank McCormick, et al.
Pageof 2